Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis

Journal of Pathology

Volumn 231, Issue 4, 2013, Pages 517-531

  Sandoval, Pilar ^a   Jiménez Heffernan, Jose Antonio ^b   Rynne Vidal, Ángela ^a   Pérez Lozano, María Luisa ^a   Gilsanz, Álvaro ^a   Ruiz Carpio, Vicente ^a   Reyes, Raquel ^a   García Bordas, Julio ^c   Stamatakis, Konstantinos ^a   Dotor, Javier ^d   Majano, Pedro L ^b   Fresno, Manuel ^a   Cabañas, Carlos ^a   Lõpez Cabrera, Manuel ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d Digna Biotech   (Spain)

Author keywords

carcinoma associated fibroblasts; mesothelial cells; mesothelial to mesenchymal transition; peritoneal metastasis

Indexed keywords

BETA1 INTEGRIN; BIOLOGICAL MARKER; FLUORESCENT DYE; TETRAZOLIUM;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER CELL CULTURE; CARCINOMA; CELL ADHESION; CELL INTERACTION; CELL POPULATION; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MESOTHELIUM CELL; MOUSE; MYOFIBROBLAST; NEOPLASM; NONHUMAN; OMENTUM; PERITONEUM METASTASIS; PHENOTYPE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STIMULATION; TUMOR BIOPSY; TUMOR CELL; TUMOR INVASION; VASCULARIZATION;

CARCINOMA-ASSOCIATED FIBROBLASTS; MESOTHELIAL CELLS; MESOTHELIAL-TO-MESENCHYMAL TRANSITION; PERITONEAL METASTASIS;

ANIMALS; BIOPSY; CELL ADHESION; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROBLASTS; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS;

EID: 84887550102     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4281     Document Type: Article

References (52)

1. Tan DS, Agarwal R, Kaye SB,. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 2006; 7 (11): 925-934.
2. de Cuba EM, Kwakman R, van Egmond M, et al., Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: future possibilities for personalised treatment by use of biomarkers. Virchows Arch 2012; 461 (3): 231-243.
3. Jayne DG, Fook S, Loi C, et al., Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89 (12): 1545-1550.
4. Koppe MJ, Boerman OC, Oyen WJ, et al., Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243 (2): 212-222.
5. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al., Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348 (5): 403-413.
6. Aroeira LS, Aguilera A, Sanchez-Tomero JA, et al., Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007; 18 (7): 2004-2013.
7. Sandoval P, Loureiro J, Gonzalez-Mateo G, et al., PPARγ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest 2010; 90 (10): 1517-1532.
8. Loureiro J, Aguilera A, Selgas R, et al., Blocking TGFβ1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 2011; 22 (9): 1682-1695.
9. Mubarak KK, Montes-Worboys A, Regev D, et al., Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis. Eur Respir J 2012; 39 (1): 133-140.
10. Li Y, Wang J, Asahina K,. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci USA 2013; 110 (6): 2324-2329.
11. Perez-Lozano ML, Sandoval P, Rynne-Vidal A, et al., Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition. PLoS One 2013; 8 (4): e60776.
12. Burleson KM, Hansen LK, Skubitz AP,. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clin Exp Metast 2004; 21 (8): 685-697.
13. Freedman RS, Deavers M, Liu J, et al., Peritoneal inflammation-a microenvironment for epithelial ovarian cancer (EOC). J Transl Med 2004; 2 (1): 23.
14. Lopez-Novoa JM, Nieto MA,. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 2009; 1 (6-7): 303-314.
15. Liotta LA, Kohn EC,. The microenvironment of the tumour-host interface. Nature 411 (6835): 375-379.
16. Orimo A, Weinberg RA,. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006; 5 (15): 1597-1601.
17. Cirri P, Chiarugi P,. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metast Rev 2012; 31 (1-2): 195-208.
18. Desmouliere A, Guyot C, Gabbiani G,. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004; 48 (5-6): 509-517.
19. Casey TM, Eneman J, Crocker A, et al., Cancer associated fibroblasts stimulated by transforming growth factor-β1 (TGFβ1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat 2008; 110 (1): 39-49.
20. Kalluri R, Zeisberg M,. Fibroblasts in cancer. Nat Rev Cancer. 2006; 6 (5): 392-401.
21. Acloque H, Adams MS, Fishwick K, et al., Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119 (6): 1438-1449.
22. Radisky DC, Kenny PA, Bissell MJ,. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 2007; 101 (4): 830-839.
23. Strippoli R, Benedicto I, Perez Lozano ML, et al., Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells. PLoS One 2012; 7 (2): e31492.
24. Arroyo AG, Sanchez-Mateos P, Campanero MR, et al., Regulation of the VLA integrin-ligand interactions through the β1 subunit. J Cell Biol 1992; 117 (3): 659-670.
25. Campanero MR, Arroyo AG, Pulido R, et al., Functional role of α2β1 and α4β1 integrins in leukocyte intercellular adhesion induced through the common β1 subunit. Eur J Immunol 1992; 22 (12): 3111-3119.
26. Aroeira LS, Aguilera A, Selgas R, et al., Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46 (5): 938-948.
27. Zeisberg EM, Potenta S, Xie L, et al., Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 2007; 67 (21): 10123-10128.
28. Potenta S, Zeisberg E, Kalluri R,. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008; 99 (9): 1375-1379.
29. Jimenez-Heffernan JA, Aguilera A, Aroeira LS, et al., Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch 2004; 444 (3): 247-256.
30. Mizutani M, Ito Y, Mizuno M, et al., Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 2010; 298 (3): F721-733.
31. Sako A, Kitayama J, Yamaguchi H, et al., Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis. J Surg Res 2003; 115 (1): 113-120.
32. Sako A, Kitayama J, Koyama H, et al., Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. Cancer Res 2004; 64 (10): 3624-3628.
33. Sodek KL, Murphy KJ, Brown TJ, et al., Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metast Rev 2012; 31 (1-2): 397-414.
34. Devuyst O, Margetts PJ, Topley N,. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol 2010; 21 (7): 1077-1085.
35. Takatsuki H, Komatsu S, Sano R, et al., Adhesion of gastric carcinoma cells to peritoneum mediated by α3β1 integrin (VLA-3). Cancer Res 2004; 64 (17): 6065-6070.
36. Watanabe T, Hashimoto T, Sugino T, et al., Production of IL-1β by ovarian cancer cells induces mesothelial cell β1-integrin expression facilitating peritoneal dissemination. J Ovarian Res 2012; 5 (1): 7.
37. Wagner BJ, Lob S, Lindau D, et al., Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β1 integrin. Int J Oncol 2011; 39 (6): 1593-1600.
38. Kenny HA, Kaur S, Coussens LM, et al., The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008; 118 (4): 1367-1379.
39. Kenny HA, Lengyel E,. MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle 2009; 8 (5): 683-688.
40. Slack-Davis JK, Atkins KA, Harrer C, et al., Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 2009; 69 (4): 1469-1476.
41. Casey RC, Skubitz AP,. CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metast 2000; 18 (1): 67-75.
42. Ziprin P, Ridgway PF, Pfistermuller KL, et al., ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNFα: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes 2003; 10 (3): 141-154.
43. Rump A, Morikawa Y, Tanaka M, et al., Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem 2004; 279 (10): 9190-9198.
44. Alkhamesi NA, Ziprin P, Pfistermuller K, et al., ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin Exp Metast 2005; 22 (6): 449-459.
45. Ksiazek K, Mikula-Pietrasik J, Catar R, et al., Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium. Int J Cancer 2010; 127 (2): 293-303.
46. Yu G, Tang B, Yu PW, et al., Systemic and peritoneal inflammatory response after laparoscopic-assisted gastrectomy and the effect of inflammatory cytokines on adhesion of gastric cancer cells to peritoneal mesothelial cells. Surg Endosc 2010; 24 (11): 2860-2870.
47. Kenny HA, Krausz T, Yamada SD, et al., Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extracellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J Cancer 2007; 121 (7): 1463-1472.
48. Cai J, Tang H, Xu L, et al., Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis 2012; 33 (1): 20-29.
49. Bellini A, Mattoli S,. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87 (9): 858-870.
50. Zeisberg EM, Potenta SE, Sugimoto H, et al., Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19 (12): 2282-2287.
51. Yamamura S, Matsumura N, Mandai M, et al., The activated transforming growth factor-β signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int J Cancer 2012; 130 (1): 20-28.
52. Rinkevich Y, Mori T, Sahoo D, et al., Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature. Nat Cell Biol 2012; 14 (12): 1251-1260.